Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17β-estradiol) in canine mammary tumours

Journal of Steroid Biochemistry and Molecular Biology

Volumn 110, Issue 1-2, 2008, Pages 76-82

  Queiroga, Felisbina L ^a   Pérez Alenza, Maria D ^b   Silvan, Gema ^b   Peña, Laura ^b   Lopes, Carlos S ^c   Illera, Juan C ^b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Canine; Estrogens; Growth hormone; Insulin like growth factor I; Malignant mammary tumours; Progesterone; Steroid hormones

Indexed keywords

ESTRADIOL; GROWTH HORMONE; PROGESTERONE; SOMATOMEDIN C; STEROID HORMONE;

ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST DYSPLASIA; BREAST TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; RADIOIMMUNOASSAY; TISSUE HOMOGENATE;

ANIMALS; DOGS; ESTRADIOL; FEMALE; GROWTH HORMONE; IMMUNOENZYME TECHNIQUES; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; PROGESTERONE; RADIOIMMUNOASSAY;

CANIS FAMILIARIS;

EID: 44649087689     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.02.005     Document Type: Article

References (57)

1. Laban C., Bustin S.A., and Jenkins P.J. The GH-IGF-I axis and breast cancer. Trends. Endocrinol. Metab. 14 (2003) 28-34
2. Rutteman G.R., Misdorp W., Van den Brom W.E., and Rijnberk A. Anterior pituitary function in female dogs with spontaneous mammary tumors. I. Growth hormone. Anticancer Res. 9 (1989) 235-239
3. Mol J.A., van Garderen E., Selman P.J., Wolfswinkel J., Rijinberk A., and Rutteman G.R. Growth hormone mRNA in mammary gland tumors of dogs and cats. J. Clin. Invest. 95 (1995) 2028-2034
4. van Garderen E., de Wit M., Voorhout W.F., Rutteman G.R., Mol J.A., Nederbragt H., and Misdorp W. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop. Am. J. Pathol. 150 (1997) 1037-1047
5. van Garderen E., and Schalken J. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system. Mol. Cell. Endocrinol. 197 (2002) 153-165
6. Illera J.C., Silvan G., Pérez-Alenza M.D., and Pena L. The possible role of IGF-I and androgens in the development of canine inflammatory mammary carcinoma. Proceedings of the Fourth International Congress on Hormonal Carcinogenesis of the mammary gland (2003)
7. Friend K.E. Cancer and the potential place for growth hormone receptor antagonist therapy. Growth Horm. IGF-I Res. 11 (2001) 121-122
8. Kooistra H.S., den Hertog E., Okkens A.C., Mol J.A., and Rijnberk A. Pulsatile secretion pattern of growth hormone during the luteal phase and mid-anoestrus in beagle bitches. J. Reprod. Fertil. 119 (2000) 217-222
9. Selman P.J., Mol J.A., Rutteman G.R., van Garderen E., and Rijnberk A. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134 (1994) 287-292
10. Selman P.J., Mol J.A., Rutteman G.R., and Rijnberk A. Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis. Eur. J. Endocrinol. 131 (1994) 413-421
11. Mol J.A., Selman P.J., Sprang E.P., van Neck J.W., and Oosterlaken-Dijksterhuis M.A. The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: a review. J. Reprod. Fertil. Suppl. 51 (1997) 339-344
12. van Garderen E., van der Poel H.J., Swennenhuis J.F., Wissink E.H., Rutteman G.R., Hellmen E., Mol J.A., and Schalken J.A. Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors. Endocrinology 140 (1999) 5907-5914
13. Rijnberk A., Kooistra H.S., and Mol J.A. Endocrine diseases in dogs and cats: similarities and differences with endocrine diseases in humans. Growth Horm. IGF Res. 13 (2003) 158-164
14. Khandwala H.M., McCutcheon I.E., Flyvbjerg A., and Friend K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 2 (2000) 215-244
15. Holly J.M., Gunnell D.J., and Davey Smith G. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?. J. Endocrinol. 162 (1999) 321-330
16. Sachdev D., and Yee D. The IGF system and breast cancer. Endocr. Relat. Cancer 8 (2001) 197-209
17. Pollak M.N. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res. Treat. 47 (1998) 209-217
18. Walden P.D., Ruan W., Feldman M., and Kleinberg D.L. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139 (1998) 659-662
19. Manni A., Wei L., Badger B., Zaenglein A., Leighton J., Shimasaki S., and Ling N. Expression of messenger RNA for insulin-like growth factors and insulin-like growth factor binding proteins by experimental breast cancer and normal breast tissue in vivo. Endocrinology 130 (1992) 1744-1746
20. Oosterlaken-Dijksterhuis M.A., Kwant M.M., Slob A., Hellmen E., and Mol J.A. IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumour cell line CMT-U335. Breast Cancer Res. Treat. 54 (1999) 11-23
21. Hamelers I.H., and Sussenbach J.S. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr. Relat. Cancer 10 (2003) 331-345
22. Queiroga F.L., Perez-Alenza M.D., Silvan G., Pena L., Lopes C., and Illera J.C. Role of steroid hormones and prolactin in canine mammary cancer. J. Steroid Biochem. Mol. Biol. 94 (2005) 181-187
23. Illera J.C., Perez-Alenza M.D., Nieto A., Jimenez M.A., Silvan G., Dunner S., and Pena L. Steroids and receptors in canine mammary cancer. Steroids 71 (2006) 541-548
24. Van der Burg B., Rutteman G.R., Blankenstein M.A., de Laat S.W., and van Zoelen E.J. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J. Cell. Physiol. 134 (1988) 101-108
25. Osborne C.K., Clemmons D.R., and Arteaga C.L. Regulation of breast cancer growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol. 37 (1990) 805-809
26. Dupont J., and Le Roith D. Insulin-like growth factor I and oestradiol promote cell proliferation of MCF-7 breast cancer cells: news insights into their synergistic effects. Mol. Pathol. 54 (2001) 149-154
27. Hamelers I.H., van Schaik R.F., van Teeffelen H.A., Sussenbach J.S., and Steenbergh P.H. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells. Exp. Cell. Res. 273 (2002) 107-117
28. Thorne C., and Lee A.V. Cross talk between estrogen receptor and IGF signaling in normal mammary gland development and breast cancer. Breast Dis. 17 (2003) 105-114
29. L.N. Owen, TMN classification of tumors in domestic animals. ED. VPH/CMO/80.20, World Health Organizaton, Geneva, 1980.
30. Misdorp W., Else R.W., Hellmen E., and Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and Cat. Second Series vol. 7 (1999), Armed Forces Institute of Pathology and World Health Organization, Washington
31. Vail D.M., and MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 18 (2000) 781-792
32. Henry C.J., Buss M.S., Hellstrom I., Hellstrom K.E., Brewer W.G., Bryan J.N., and Siegall C.B. Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma. Clin. Cancer Res. 11 (2005) 751-755
33. Queiroga F.L., Perez-Alenza M.D., Silvan G., Pena L., Lopes C., and Illera J.C. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance. Anticancer Res. 25 (2005) 4269-4275
34. Laumbacher B., Fellerhoff B., Herzberger B., and Wank R. Do dogs harbour risk factors for human breast cancer?. Med. Hypotheses 67 (2006) 21-26
35. Queiroga F.L., Alves A., Pires I., and Lopes C. Expression of Cox-1 and Cox-2 in canine mammary tumours. J. Comp. Pathol. 136 (2007) 177-185
36. Cohen P., Clemmons D.R., and Rosenfeld R.G. Does the GH-IGF axis play a role in cancer pathogenesis?. Growth Horm. IGF Res. 10 (2000) 297-305
37. Jenkins P.J., Mukherjee A., and Shalet S.M. Does growth hormone cause cancer?. Clin. Endocrinol. 64 (2006) 115-121
38. Mol J.A., Henzen-Logmans S.C., Hageman P., Misdorp W., Blankenstein M.A., and Rijnberk A. Expression of the gene encoding growth hormone in the human mammary gland. J. Clin. Endocrinol. Metab. 80 (1995) 3094-3096
39. Raccurt M., Lobie P.E., Moudilou E., Garcia-Caballero T., Frappart L., Morel G., and Mertani H.C. High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. J. Endocrinol. 175 (2002) 307-318
40. Mukhina S., Mertani H.C., Guo K., Lee K.O., Gluckman P.D., and Lobie P.E. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15166-15171
41. Waters M.J., and Conway-Campbell B.L. The oncogenic potential of autocrine human growth hormone in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14992-14993
42. Ordás J., Millán Y., de los Monteros A.E., Reymundo C., and de las Mulas J.M. Immunohistochemical expression of progesterone receptors, growth hormone and insulin growth factor-I in feline fibroadenomatous change. Res. Vet. Sci. 76 (2004) 227-233
43. Rutteman G.R., and Misdorp W. Hormonal background of canine and feline mammary tumours. J. Reprod. Fert. 47 (1993) 483-487
44. Pena L., Silvan G., Pérez-alenza M.D., Nieto A., and Illera J.C. Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study. J. Steroid Biochem. Mol. Biol. 43 (2003) 211-216
45. Druckmann R. Progestins and their effects on the breast. Maturitas 10 (2003) 59-69
46. Clarke R., Leonessa F., Welch J.N., and Skaar T.C. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol. Rev. 53 (2001) 25-72
47. Milewicz T., Gregoraszczuk E.L., Augustowska K., Krzysiek J., Sztefko K., and Rys J. Progesterone but not estradiol 17beta potentiates local GH secretions by hormone-dependent breast cancer explants. An in vitro study. Exp. Clin. Endocrinol. Diabetes 113 (2005) 127-132
48. Song R.X., Zhang Z., Chen Y., Bao Y., and Santen R.J. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 148 (2007) 4091-4101
49. Mol J.A., Lantinga-van Leeuwen I.S., van Garderen E., Selman P.J., Oosterlaken-Dijksterhuis M.A., Schalken J.A., and Rijnberk A. Mammary growth hormone and tumorigenesis-lessons from the dog. Vet. Q. 21 (1999) 111-115
50. Mol J.A., van Garderen E., Rutteman G.R., and Rijnberk A. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. J. Steroid Biochem. Mol. Biol. 57 (1996) 67-71
51. Rijnberk A., and Mol J.A. Progestin-induced hypersecretion of growth hormone: an introductory review. J. Reprod. Fertil. Suppl. 51 (1997) 335-338
52. Mol J.A., Lantinga-van Leeuwen I., van Garderen E., and Rijnberk A. Progestin-induced mammary growth hormone (GH) production. Adv. Exp. Med. Biol. 480 (2000) 71-76
53. Gregoraszczuk E.L., Milewicz T., Kolodziejczyk J., Krzysiek J., Basta A., Sztefko K., Kurek S., and Stachura J. Progesterone-induced secretion of growth hormone, insulin-like growth factor I and prolactin by human breast cancer explants. Gynecol. Endocrinol. 15 (2001) 251-258
54. Kahlert S., Nuedling S., van Eickels M., Vetter H., Meyer R., and Grohe C. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275 (2000) 18447-18453
55. Helle S.I. The insulin-like growth factor system in advanced breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 18 (2004) 67-79
56. Yee D., Paik S., Lebovic G.S., Marcus R.R., Favoni R.E., Cullen K.J., Lippman M.E., and Rosen N. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3 (1989) 509-517
57. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S., Deroo B., Rosner B., Speizer F.E., and Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396